Document Detail


Addition of mitiglinide to pioglitazone monotherapy improves overall glycemic control in Japanese patients with type 2 diabetes: a randomized double blind trial.
MedLine Citation:
PMID:  19352048     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 16-week, multicenter, randomized, double blind, parallel-group study was performed to examine whether additional administration of mitiglinide improves glycemic control in Japanese type 2 diabetic patients who are insufficiently controlled by pioglitazone monotherapy. Japanese adult type 2 diabetic patients were at first treated with diet plus pioglitazone 15-30 mg/day for 4 weeks then randomized to receive additional mitiglinide 5 or 10 mg or placebo tid for a further 16 weeks. In all, 381 patients were randomized. At final evaluation, glycated hemoglobin (HbA(1C)) was reduced by (mean +/- SD) -0.02 +/- 0.60% in the pioglitazone monotherapy group and by -0.45 +/- 0.77% and -0.67 +/- 0.59% in the mitiglinide 5 and 10 mg combination groups, respectively (both p<0.001 vs. pioglitazone monotherapy group). The percentage of patients who achieved HbA(1C) targets was significantly (p<0.001) higher in the mitiglinide combination groups than in the pioglitazone monotherapy group. Significant improvements in fasting plasma glucose and postprandial plasma glucose were noted in the mitiglinide combination groups versus the pioglitazone monotherapy group. No increase in adverse events was noted when mitiglinide was administered concomitantly with pioglitazone monotherapy. Hypoglycemic adverse events were infrequently and similarly observed in all three groups. Body weight gain and edema presented no clinical problem. HbA(1C) was significantly improved in the mitiglinide combination groups compared with the pioglitazone monotherapy group, and significantly more patients achieved HbA(1C) targets. Therefore mitiglinide effectively improves glycemic control in type 2 diabetic patients who are inadequately controlled by pioglitazone monotherapy.
Authors:
Kohei Kaku; Shun-ichi Tanaka; Hideki Origasa; Masatoshi Kikuchi; Yasuo Akanuma
Related Documents :
19051338 - Characterization of the anti-diabetic and antioxidant effects of rehmannia glutinosa in...
16940388 - Improvement in coronary vascular dysfunction produced with euglycaemic control in patie...
20824678 - Efficacy and safety of saxagliptin in combination with metformin compared with sitaglip...
20629618 - Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone.
20858228 - The association between blood glucose and oxidized lipoprotein(a) in healthy young women.
15909858 - Assessment of glycemia in diabetes mellitus--self-monitoring of blood glucose.
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2009-04-07
Journal Detail:
Title:  Endocrine journal     Volume:  56     ISSN:  1348-4540     ISO Abbreviation:  Endocr. J.     Publication Date:  2009  
Date Detail:
Created Date:  2009-08-26     Completed Date:  2009-11-06     Revised Date:  2011-06-16    
Medline Journal Info:
Nlm Unique ID:  9313485     Medline TA:  Endocr J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  657-64     Citation Subset:  IM    
Affiliation:
Diabetes and Endocrine Division, Department of Medicine, Kawasaki Medical School, Okayama, Japan. kka@med.kawasaki-m.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Blood Glucose / metabolism
Diabetes Mellitus, Type 2 / drug therapy*
Diabetic Diet
Double-Blind Method
Drug Therapy, Combination
Female
Hemoglobin A, Glycosylated / metabolism
Humans
Hypoglycemic Agents / administration & dosage*
Isoindoles / administration & dosage*
Male
Middle Aged
Thiazolidinediones / administration & dosage*
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Hemoglobin A, Glycosylated; 0/Hypoglycemic Agents; 0/Isoindoles; 0/Thiazolidinediones; 0/mitiglinide; 111025-46-8/pioglitazone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Incidence of symptomatic vertebral fracture with high-dose glucocorticoid treatment in the Chiba-Shi...
Next Document:  Endothelial dysfunction is related to aldosterone excess and raised blood pressure.